01
Lactobacillus reuteri produces reuterin and organic acids that directly inhibit antibiotic-resistant pathogens in the post-antibiotic gut.
Gut · LPB-GA-008
Lorbiotics · LPB-GA-008
Clinical DomainGastroenterologyLorbiotics Infant AAD
Triple-layer gut protection for babies on antibiotics. When your child needs medication, this formula shields their developing gut from the side effects.
☆☆☆☆☆No reviews yet10BCFU at expiry · per dose
3Active strains
Capsule / SachetDosage form
- Capsules / Sachets
- Allergen Free
- In Vitro Test
- Clinical Test
- 24 Month Stability
1
71%
The headline result
Up to 71% reduction in antibiotic-associated diarrhea risk with L. rhamnosus GG — the most extensively studied paediatric probiotic strain, endorsed alongside S. boulardii by ESPGHAN guidelines.
The science
Why Infant AAD works.
Lorbotics-Infant AAD is a clinically advanced triple-action probiotic synbiotic specially formulated to prevent and manage antibiotic-associated diarrhea (AAD) in infants and children.
It combines three well studied probiotic strains Lactobacillus reuteri, Lactobacillus rhamnosus GG, and Saccharomyces boulardii with Vitamin D3 and Biotin for comprehensive gastrointestinal protection during and after antibiotic therapy.
Why it matters:
Up to 30% of children on broad-spectrum antibiotics develop AAD due to disruption of gut microflora and overgrowth of pathogens like Clostridioides difficile.
Clinically supported components:
Lactobacillus rhamnosus GG – Most extensively studied paediatric probiotic; can reduce AAD risk by up to 71%.
Saccharomyces boulardii – Endorsed by ESPGHAN guidelines for AAD prevention.
Lactobacillus reuteri – Provides additional antimicrobial and intestinal barrier protection.
Vitamin D3 + Biotin – Help replenish micronutrients depleted by antibiotics and support mucosal healing and immune function.
Therapeutic targets
- 01Prevention of antibiotic-associated diarrhea
- 02Clostridioides difficile protection
- 03Intestinal barrier restoration
- 04Gut dysbiosis counteraction
- 05Mucosa inflammation reduction
- 06Safe concurrent use with antibiotics
“Lorbotics-Infant AAD is a clinically advanced triple-action probiotic synbiotic specially formulated to prevent and manage antibiotic-associated diarrhea (AAD) in infants and children.”
Lorbiotics Infant AAD · Gastroenterology
Mechanism of action
How it works, step by step.
The documented biological pathway — exactly how each component acts inside the body.
02
Lactobacillus rhamnosus binds intestinal mucins via mucus-binding proteins (MUBs), physically blocking enteropathogens while upregulating tight-junction protein ZO-1 to strengthen the intestinal barrier and reduce permeability linked to antibiotic-associated diarrhea (AAD).
03
Saccharomyces boulardii, inherently resistant to antibiotics due to its eukaryotic nature, stays metabolically active during therapy. It secretes a 54 kDa serine protease that cleaves and neutralizes C. difficile toxins A and B, preventing toxin-induced mucosal damage.
04
Together, these three organisms restore colonisation resistance, re-establish a protective short-chain fatty acid (SCFA)-rich environment, and accelerate microbiome recovery after antibiotic treatment.
Inside the formula
Every ingredient earns its place.
The exact composition of Lorbiotics Infant AAD — each organism and active listed at its formulated dose.
| Organism / active | Documented role | Dose |
|---|---|---|
| Lactobacillus reuteri | — | 0.2 B CFU |
| Lactobacillus rhamnosus | — | 1 B CFU |
| Saccharomyces boulardii | — | 350mg |
| Vitamin D3 | — | 400 IU |
| Biotin | Vitamin B7 | — |
The practical bits
How to take it.
Dosage
Infants & Children: 1 sachet/capsule daily during antibiotic therapy and for 4 weeks after completion. Administer with room-temperature water or formula — do not use hot liquids. Or as advised by physician.
In the pack
Capsule / Sachet · 60 per Pack
Contains Vitamin D3 400 IU + Biotin to replenish antibiotics-depleted micronutrients and support mucosal healing.
Certifications
- WHO-GMP
- ISO 13485
- Allergen Free
- Clinical Test
- 24 Month Stability
Note: Not for medicinal use or for curative action. Recommended to use as food supplement only
Reviews
What people say after they've actually taken it.
—
☆☆☆☆☆No reviews yet
☆☆☆☆☆
No reviews yet
Reviews come from verified buyers only. Once customers who've purchased Infant AAD share their experience, you'll see it here.
Evidence base
Peer-reviewed references.
Every claim on this page traces back to published literature. The full citation list for Lorbiotics Infant AAD.
- 01Szajewska H, Mrukowicz JZ. J Pediatr Gastroenterol Nutr. 2001 33(Suppl 2):S17-25.
- 02Johnston BC, et al. Cochrane Database Syst Rev. 2011 (11):CD004827.
- 03Szajewska H, et al. Aliment Pharmacol Ther. 2007 25(8):871-81.
- 04Probiotical S.p.A. LPB-GE-INFANTAAD · L. reuteri + L. rhamnosus + S. boulardii 1.2B + Vit D3 + Biotin · 60 Caps / Sachet
Often paired with
